Literature DB >> 5158782

Effect of L-dopa on speech in Parkinsonism. An EMG study of labial articulatory function.

R Leanderson, B A Meyerson, A Persson.   

Abstract

The articulatory function of the labial musculature has been investigated electromyographically before and after treatment with l-dopa in patients with Parkinsonism who had dysarthria. Before medication the EMG traces generally showed a constant, abnormally increased, tonic activity, together with disturbed reciprocal innervation, which impaired the articulatory activity. After medication the tonic hyperactivity was reduced and the reciprocal innervation re-established. This normalization of the EMG articulatory pattern was paralleled by an improvement of the dysarthria.

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5158782      PMCID： PMC1083501          DOI： 10.1136/jnnp.34.6.679

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  8 in total

1.  Dysarthria in post-encephalitic parkinsonism.

Authors:  F GREWEL
Journal:  Acta Psychiatr Neurol Scand       Date:  1957

2.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

3.  Electromyographic studies of facial muscle activity in speech.

Authors:  A Persson; R Leanderson; S Ohman
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1969-09

4.  Oral L-dopa treatment of parkinsonism.

Authors:  N E Andén; A Carlsson; J Kerstell; T Magnusson; R Olsson; B E Roos; B Steen; G Steg; A Svanborg; G Thieme; B Werdinius
Journal:  Acta Med Scand       Date:  1970-04

5.  [Quantitative analysis and mechanisms of bradykinesia in patients with Parkinson's disease].

Authors:  P Schneider
Journal:  Dtsch Z Nervenheilkd       Date:  1968

6.  Electromyographic studies of the function of the facial muscles in dysarthria.

Authors:  R Leanderson; A Persson; S Ohman
Journal:  Acta Otolaryngol Suppl       Date:  1969

7.  [The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia].

Authors:  W BIRKMAYER; O HORNYKIEWICZ
Journal:  Wien Klin Wochenschr       Date:  1961-11-10       Impact factor: 1.704

8.  Treatment of Parkinsonism with Laevo-dopa.

Authors:  C Mawdsley
Journal:  Br Med J       Date:  1970-02-07
  8 in total
  9 in total

1.  Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.

Authors:  Jan Rusz; Roman Cmejla; Hana Růžičková; Jiří Klempíř; Veronika Majerová; Jana Picmausová; Jan Roth; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2012-07-08       Impact factor: 3.575

2.  Face-referenced measurement of perioral stiffness and speech kinematics in Parkinson's disease.

Authors:  Shin Ying Chu; Steven M Barlow; Jaehoon Lee
Journal:  J Speech Lang Hear Res       Date:  2015-04       Impact factor: 2.297

3.  Speech therapy for patients with Parkinson's disease.

Authors:  S Scott; F I Caird
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-24

4.  Speech therapy for Parkinson's disease.

Authors:  S Scott; F I Caird
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

5.  Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease.

Authors:  Sabine Skodda; Wenke Visser; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2009-12-12       Impact factor: 3.575

6.  Effects of dopamine D1 and D2 receptor antagonists on laryngeal neurophysiology in the rat.

Authors:  Xin Feng; Victor M Henriquez; Judith R Walters; Christy L Ludlow
Journal:  J Neurophysiol       Date:  2009-06-17       Impact factor: 2.714

7.  Research-based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management.

Authors:  C K Broadfoot; D Abur; J D Hoffmeister; C E Stepp; M R Ciucci
Journal:  Perspect ASHA Spec Interest Groups       Date:  2019-10-11

8.  Dysarthria in individuals with Parkinson's disease: a protocol for a binational, cross-sectional, case-controlled study in French and European Portuguese (FraLusoPark).

Authors:  Serge Pinto; Rita Cardoso; Jasmin Sadat; Isabel Guimarães; Céline Mercier; Helena Santos; Cyril Atkinson-Clement; Joana Carvalho; Pauline Welby; Pedro Oliveira; Mariapaola D'Imperio; Sónia Frota; Alban Letanneux; Marina Vigario; Marisa Cruz; Isabel Pavão Martins; François Viallet; Joaquim J Ferreira
Journal:  BMJ Open       Date:  2016-11-17       Impact factor: 2.692

9.  Levodopa-Based Changes on Vocalic Speech Movements during Prosodic Prominence Marking.

Authors:  Tabea Thies; Doris Mücke; Richard Dano; Michael T Barbe
Journal:  Brain Sci       Date:  2021-05-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.